|1.||Xu, Xiaoyu: 1 article (01/2009)|
|2.||Zhang, Wenliang: 1 article (01/2009)|
|3.||Li, Ao: 1 article (01/2009)|
|4.||Wang, Shumei: 1 article (01/2009)|
|5.||Dong, Wei: 1 article (01/2009)|
|2.||Liver Neoplasms (Liver Cancer)
01/01/2009 - "To investigate the anticancer effects of Erbie San on the rats bearing Walker-256 liver cancer and the potential mechanism of its angiogenesis effects. "
01/01/2009 - "Erbie San can effectively inhibit the growth of Walker-256 liver cancer of rats and can inhibit the expression of VEGF but increase the expression of endostatin, which suggest that Erbie San has the inhibition of angiogenesis which is responsible for its anticancer effects."
01/01/2009 - "[Effects of Erbie San on Walker-256 liver cancer and adjustment to unbalance of VEGF/endostatin in rats]."
|2.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)